-Down to Earth Government sidelines its committee of experts to set up new panel to review India's intellectual property rights policy The politics of protecting intellectual property rights (IPR) is becoming more curiouswith the commerce ministry setting up a think tank to draft a national IPR policy while sidelining a committee of experts it had set up earlier. Annoyed academics who were asked to help formulate the policy in July this year...

-The Times of India NEW DELHI: The drug price regulator has mandated Companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'. The move is aimed at spanning the...

-The Times of India MUMBAI: Some multinational Companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law. Corporates such as Japanese firm Otsuka Pharmaceuticals, US-based Bristol Myers-Squibb (BMS) and Swiss firm Novartis are deferring the launch of medicines critical for treatment of serious non-communicable diseases like cancer, HIV,...

-Economic and Political Weekly   The runaway growth in states of subsidised solar pumps, which provide quality energy at near-zero marginal cost, can pose a bigger threat of groundwater over-exploitation than free power has done so far. The best way to meet this threat is by paying farmers to "grow" solar power as a remunerative cash crop. Doing so can reduce pressure on aquifers, cut the subsidy burden on electricity Companies, reduce...

-The Times of India India's intellectual property (IP) law has been hailed as one of the most progressive for safeguarding public interest, and several nations like Argentina, the Philippines and Brazil are looking to learn from it. Senior advocate and former UN special rapporteur on the right to health Anand Grover talks to Rema Nagarajan about the pressure the country is facing to change its IP laws, primarily from the US. *...